Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Retained Earnings of -$112.5 million for Q1 2026, down 143.2% year-over-year from $260.3 million in Q1 2025, and down 135.48% quarter-over-quarter from $317.0 million in Q4 2025.
Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026) Analysis & Trends
Phibro Animal Health's Retained Earnings history runs 14 years deep, the most recent figure standing at -$112.5 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 143.2% year-over-year to -$112.5 million; the TTM figure through Mar 2026 stood at -$112.5 million (down 143.2% YoY), while the FY2025 annual figure was -$124.0 million, changed 0.4% from the prior year.
- Retained Earnings for Q1 2026 stood at -$112.5 million, down from $317.0 million in the prior quarter.
- The five-year high for Retained Earnings was $317.0 million in Q4 2025, with the low at -$124.0 million in Q2 2025.
- The 5-year median for Retained Earnings is $244.3 million (2024), against an average of $82.9 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 149.97% in 2024, then jumped 337.51% in 2025.
- Phibro Animal Health's Retained Earnings stood at -$116.5 million in 2022, then grew by 5.93% to -$109.6 million in 2023, then soared by 322.89% to $244.3 million in 2024, then increased by 29.73% to $317.0 million in 2025, then sank by 135.48% to -$112.5 million in 2026.
- Business Quant data shows PAHC's Retained Earnings at -$112.5 million in Q1 2026, $317.0 million in Q4 2025, and $294.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Phibro Animal Health | 1.47 Bn | 1.39 Bn | 125.68 Mn | 336.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.47 Mn |
| Dec 31, 2025 | 316.96 Mn |
| Sep 30, 2025 | 294.36 Mn |
| Jun 30, 2025 | -124.02 Mn |
| Mar 31, 2025 | 260.34 Mn |
| Dec 31, 2024 | 244.33 Mn |
| Sep 30, 2024 | -123.94 Mn |
| Jun 30, 2024 | -123.53 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | -109.62 Mn |
| Sep 30, 2023 | 248.04 Mn |
| Jun 30, 2023 | -114.21 Mn |
| Mar 31, 2023 | -117.75 Mn |
| Dec 31, 2022 | -116.53 Mn |
| Sep 30, 2022 | 246.74 Mn |
| Jun 30, 2022 | 247.75 Mn |
| Mar 31, 2022 | 245.12 Mn |
| Dec 31, 2021 | -128.81 Mn |
| Sep 30, 2021 | 219.69 Mn |
| Jun 30, 2021 | -115.29 Mn |